PDT Partners’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,481
| Closed | -$344K | – | 951 |
|
|
2022
Q1 | $344K | Sell |
1,481
-3,255
| -69% | -$756K | 0.03% | 677 |
|
|
2021
Q4 | $1.87M | Buy |
4,736
+788
| +20% | +$310K | 0.14% | 244 |
|
|
2021
Q3 | $1.77M | Buy |
3,948
+38
| +1% | +$17K | 0.13% | 262 |
|
|
2021
Q2 | $1.52M | Sell |
3,910
-1,838
| -32% | -$715K | 0.1% | 301 |
|
|
2021
Q1 | $2.06M | Buy |
5,748
+1,010
| +21% | +$363K | 0.15% | 264 |
|
|
2020
Q4 | $2.33M | Sell |
4,738
-378
| -7% | -$185K | 0.16% | 233 |
|
|
2020
Q3 | $1.66M | Sell |
5,116
-1,020
| -17% | -$331K | 0.11% | 236 |
|
|
2020
Q2 | $2.24M | Buy |
6,136
+1,828
| +42% | +$666K | 0.15% | 200 |
|
|
2020
Q1 | $916K | Buy |
4,308
+235
| +6% | +$50K | 0.07% | 238 |
|
|
2019
Q4 | $1.68M | Buy |
4,073
+2,773
| +213% | +$1.14M | 0.1% | 208 |
|
|
2019
Q3 | $459K | Buy |
+1,300
| New | +$459K | 0.03% | 346 |
|